Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design and analysis of a clinical trial using previous trials as historical control.
Schoenfeld DA, Finkelstein DM, Macklin E, Zach N, Ennist DL, Taylor AA, Atassi N; Pooled Resource Open-Access ALS Clinical Trials Consortium. Schoenfeld DA, et al. Among authors: atassi n. Clin Trials. 2019 Oct;16(5):531-538. doi: 10.1177/1740774519858914. Epub 2019 Jul 1. Clin Trials. 2019. PMID: 31256630 Free PMC article.
ALSUntangled No. 16: cannabis.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 Jun;13(4):400-4. doi: 10.3109/17482968.2012.687264. Amyotroph Lateral Scler. 2012. PMID: 22632446 Review. No abstract available.
ALSUntangled No. 11: Nu Tech Mediworld.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2011 Jul;12(4):309-11. doi: 10.3109/17482968.2011.589205. Amyotroph Lateral Scler. 2011. PMID: 21702736 No abstract available.
ALSUntangled 15: coconut Oil.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 May;13(3):328-30. doi: 10.3109/17482968.2012.671629. Epub 2012 Apr 3. Amyotroph Lateral Scler. 2012. PMID: 22471904 No abstract available.
Safety, tolerability and pharmacodynamics of a skeletal muscle activator in amyotrophic lateral sclerosis.
Shefner J, Cedarbaum JM, Cudkowicz ME, Maragakis N, Lee J, Jones D, Watson ML, Mahoney K, Chen M, Saikali K, Mao J, Russell AJ, Hansen RL, Malik F, Wolff AA; Neals/Cytokinetics Study Team. Shefner J, et al. Amyotroph Lateral Scler. 2012 Sep;13(5):430-8. doi: 10.3109/17482968.2012.684214. Epub 2012 May 16. Amyotroph Lateral Scler. 2012. PMID: 22591195 Clinical Trial.
ALSUntangled No. 14: Mototab.
ALSUntangled Group. ALSUntangled Group. Amyotroph Lateral Scler. 2012 Jan;13(1):161-4. doi: 10.3109/17482968.2012.645410. Amyotroph Lateral Scler. 2012. PMID: 22214359
Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M; Northeast and Canadian Amyotrophic Lateral Sclerosis consortia. Aggarwal SP, et al. Lancet Neurol. 2010 May;9(5):481-8. doi: 10.1016/S1474-4422(10)70068-5. Epub 2010 Apr 1. Lancet Neurol. 2010. PMID: 20363190 Free PMC article. Clinical Trial.
Analysis of start-up, retention, and adherence in ALS clinical trials.
Atassi N, Yerramilli-Rao P, Szymonifka J, Yu H, Kearney M, Grasso D, Deng J, Levine-Weinberg M, Shapiro J, Lee A, Joseph L, Macklin EA, Cudkowicz ME. Atassi N, et al. Neurology. 2013 Oct 8;81(15):1350-5. doi: 10.1212/WNL.0b013e3182a823e0. Epub 2013 Sep 4. Neurology. 2013. PMID: 24005339 Free PMC article. Review.
130 results